Market Insights
The global hypodermic needles market garnered US$ 3,519.53 million in 2021 and is speculated to account for US$ 5,529.28 million by 2028, expanding at a CAGR of 6.7% during 2021–2028.
The increasing prevalence of chronic diseases and surging demand for vaccines are the potential parameters assisting the market growth while the availability of alternatives hamper the expansion of global hypodermic needles market.
The high prevalence of blood-borne diseases, active government participation to implement stringent regulations, increasing demand for injectable drugs and vaccines, and untapped potential in the emerging economies are the primary elements driving the growth of safety needles market. Key market players have been focusing on organic strategies such as product launch and expansions and also involved in inorganic developments such as collaborations and partnerships to enhance their regional dominance. The organic developments account for 60% of the strategic growth and the inorganic activities contributes to 40% of the total organizational development.
Regionally, North America held the major share of the global hypodermic needles market and is likely to retain its dominance throughout the forecast period. Asia Pacific is likely to spur with the highest CAGR over the forecast period.
COVID-19 Impact
The Enormous Demand for Needles and Syringes During the Pandemic Surged the Growth of the Global Hypodermic Needles Market
The global COVID-19 pandemic led to increased hospital admissions followed by tests and medications that spurred the growth of market growth. The rise in COVID-19 vaccinations resulted in the enormous demand for needles and syringes. The vaccine campaign highlighted the utility of needles. Major market players capitalized the opportunity to quench the unprecedented demand for single-use needles. The pandemic necessitated the rapid vaccine development for curbing the disease. The vaccines approved for COVID-19 prevention were administered intramuscularly and subcutaneously using hypodermic needles. Several manufacturers maintained the robust supply chain to meet the requirement for continuous vaccination during the pandemic.
In January 2021, BD distributed 800 million syringes and needles to various hospitals in the US, as the company worked closely with Coronavirus Task Force, the US department of Health and Human Services. The hypodermic needles market in Europe witnessed a substantial growth due to highest number of COVID cases reported in Italy, Germany, France, Spain, and the UK. In July 2020, BD received a huge order of 65 million needles and syringes from the UK government to support country’s vaccination efforts. In Asia Pacific, pandemic hit the global hypodermic needles market moderately. Low-income countries in the region faced the shortage of healthcare infrastructure and supply-chain disruption. However, the market players were engrossed in medical developments seeing the demand for hypodermic needles. Misawa Medical Industry developed ‘low dead space needles’ that can reduce the quantity of medicinal liquid left in the syringe.
Future Trends
Technological Advancements in the Design of Hypodermic Needles
Pharmaceutical industry has been witnessing a large number of advanced interventions to treat several chronic diseases.There has been a greater need for devices that can allow patients or non-clinicians to administer injectable medications safely. Needle-free jet injector is one of the alternatives, but it is relatively expensive and less feasible for wide distribution. Hence, integrating advanced technology to make hypodermic needles more ergonomic became essential. In August 2020, scientists at MIT developed a prototype hypodermic needle with a syringe incorporating two barrels containing viscous medication and biocompatible lubricating fluid. Several manufacturers are working on precision-engineered needles and needlestick prevention technologies to excel in challenging applications. Most companies are providing safe designs and less painful injections to ensure therapeutic success.Hypodermic needles are undergoing controlled manufacturing and robust inspection for quality assurance.
Drivers
Increasing Prevalence of Chronic Diseases
Chronic diseases such as diabetes, CVDs, autoimmune disorders, and various types of cancer stands among the leading causes of death and disability.According to the Center for Disease Control and Prevention (CDC), around 6 out of 10 people suffered from at least one chronic disease in the US in 2019. Cardiovascular disorders cause high rate of mortality across the world with an estimated 17.9 million death cases every year. Diabetes is another life-threatening chronic disease with no functional cure. The exogenous insulin is usually administered to diabetic patients through a subcutaneous route. The wide acceptance of hypodermic needles for insulin delivery, enabling self-administration and accurate dosing drives the hypodermic needles market. Also, most biotherapeutics are injected using hypodermic needle injections as they provide a low-cost, rapid, and direct delivery of molecules.
Surging Demand for Vaccines
According to the WHO, around 90% injections are used for curative care worldwide. Immunization injections account for around 5%. An increasing demand for vaccines has surfaced as a key factor behind the growth of the global hypodermic needles market. Moreover, increased immunization coverage against preventable diseases provided by the Universal Immunization Program (UIP) is fueling the market growth. UNICEF’s joint efforts have made vaccines safer and more accessible. Apart from this, COVID-19 vaccine rollouts highlighted the critical role of needles, syringes, and other immunization tools. In July 2020, Smiths Medical partnered with the US government and received a US$ 20 million investment to increase the production of syringes and needles as a part of Operation Warp Speed Vaccine program.
Restraints
Availability of Alternatives
The drawbacks of needle-based injections are well-known. Psychological resistance to self-injection or needle-phobia is documented across large demographic groups. In case of diabetes management, self-injection systems such as wearable injectors, pen-injectors, and needle-free injectors provide patients unmatched control over their treatment, thus restricting the growth of hypodermic needles market. The use of microneedles is gaining traction for being minimally invasive, pain alleviating, and infection-resistant, eventually curbing the concerned market growth. Also, hypodermic needles market is facing stiff competition created by needle-free injectors which are technically advanced and administer highly viscous drug products. Such alternatives posing challenges to the use of hypodermic needles are likely to hinder the market growth.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Global Hypodermic Needles Market: Strategic Insights
Market Size Value in US$ 3,519.53 million in 2021 Market Size Value by US$ 5,529.28 million by 2028 Growth rate CAGR of 6.7% from 2021 to 2028 Forecast Period 2021-2028 Base Year 2021
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Global Hypodermic Needles Market: Strategic Insights
| Market Size Value in | US$ 3,519.53 million in 2021 |
| Market Size Value by | US$ 5,529.28 million by 2028 |
| Growth rate | CAGR of 6.7% from 2021 to 2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Segmentation
By Type
Clinical Benefits Over Conventional Syringes Spurred the Segmental Growth
The global hypodermic needles market, by type, is split into safety and non-safety needles. The former held the largest market share in 2021 and is anticipated to surge at the highest CAGR over the forecast period. A safety syringe has an in-built safety mechanism to lower the risk of needlestick injuries. Several countries have introduced regulations to ensure the use of safety syringes and prevent the re-use of needles. This helped expedite the use of safety syringes over conventional ones. Key players offering safety needles include BD and Cardinal Health. BD manufactures active and passive needle-based safety systems and Cardinal Health provides Monoject and Magellan safety needles and syringes.
Non-safety needles are low-cost and provide sterile injections with proper usage. The segmental growth can be attributed to the regular use in vaccination and the increasing birth rate in developing countries demanding more vaccines. The general use hypodermic needles manufactured by BD feature a regular bevel and wall that provide extra smooth vein entry with minimal drag.
Hypodermic Needles Market, by Type – 2021 and 2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
By Application
Chronic Diseases and the Demand for Vaccination Upheld the Segment’s Dominance
Based on application, the global hypodermic needles market is segmented into drug delivery, vaccination, and blood specimen collection. The drug delivery segment dominated the market in 2021 with the largest revenue share and is projected to record the highest CAGR during the forecast period. The injectable mode of drug delivery system offers a large surface area for systematic absorption. The segmental growth can be accustomed to increasing prevalence of chronic diseases and rising demand for vaccines, insulin, human growth hormone, and modern medicines. Besides, biosimilar products and low-cost hypodermic needles are preferred choices for drug delivery. Several companies are conducting clinical trials on biosimilars that can potentially offer lucrative opportunities over the forecast period.
The vaccination segment was the second-largest market occupant in 2021 with a considerable demand and growth potential. Vaccination saves millions of lives every year. Governments across the world are heavily investing to alleviate the global disease burden, specifically with the aid of vaccines. Vaccination is often perceived as the first line of defence to shield any epidemic that can possibly lead to healthcare emergencies. Several global organizations in collaboration with regional government undertook initiatives to procure large quantity of syringes and needles for vaccination rollout. The segmental growth is ascribed to the growing epidemic potential, emphasis on therapeutic vaccines, and emerging markets.
Regional Insights
Geographically, the global hypodermic needles market is segmented into North America, Europe, Asia Pacific (APAC), South & Central America (SCAM), and Middle East & Africa (MEA).
North America held the largest market share in 2021 and is forecasted to retain its dominance till 2028. The region’s highest market occupancy is attributed to the aspects such as increasing blood donations, growing prevalence of infectious diseases, high-end infrastructure for hospitals and clinical laboratories, increasing surgical procedures, and the developments by major market players. In the US, the rising elderly population susceptible to various disorders and the growing cases of cancer, diabetes, chronic pain, and gastrointestinal diseases are likely to trigger the growth of hypodermic needles market. Cancer, diabetes, and autoimmune diseases are getting prevalent in Canada. Around 11 million Canadians are living with diabetes or prediabetic conditions. People in the country suffering from type-1 diabetes require frequent insulin doses, thereby bolstering the demand for syringes and hypodermic needles.
Asia Pacific hypodermic needles market is likely to expand with the highest CAGR over the forecast period. the rising adoption of hypodermic needles, developing healthcare infrastructure, extensive R&D activities, and the high prevalence of cancer, CVDs, and diabetes are the primary parameters soaring the market growth. In China, the market growth is largely driven by the growing prevalence of blood-borne diseases, chronic diseases, and consciousness about viable treatment options. Besides, the geriatric chunk in the country is likely to develop several chronic disorders. The Indian hypodermic needles market thrives on the rising chronic and lifestyle-associated diseases, growing elderly population, and increasing awareness towards medication and healthcare.
Lucrative Regions for Hypodermic Needles Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Key Market Players:
- Exelint International, Co. (US)
- Terumo Corporation (Japan)
- BD (US)
- B.Braun Melsungen AG (Germany)
- Catalent Inc (US)
- Cardinal Health Inc (US)
- Vita Needle Company (US)
- Connecticut Hypodermics Inc (US)
- Vygon (France)
- Nipro Corp (Japan)
- Barber of Sheffield (UK)
- Retractable Technologies, Inc. (US)
- Air-Tite Products Co., Inc (US)
Key Developments:
December 2018:
Terumo announced the European launch of Biosimilar using its PLAJEX pre-filled syringes.October 2021:
BD hit 2 billion injection device milestone in the support of global COVID-19
vaccination efforts.September 2019:
B.Braun and Philips launched Onvision needle tip tracking, a breakthrough in real-time ultrasound guidance for regional anesthesia.
Report Coverage
The global hypodermic needles market research report provides detailed insights into the market in terms of size, share, trends, and forecasts. It delivers crisp and precise know-how of drivers, restraints, opportunities, segments, and industrial landscape. The COVID-19 impact analysis is discussed with the consequences followed in global and regional markets. A list of key market players with their respective developments in recent years has been reserved as a special mention.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Application, End User, and Usage
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, RoAPAC, RoE, RoMEA, RoSCAM, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The Asia Pacific is offering lucrative opportunities for market growth owing to large patient population and increasing immunization across the region.
The factors that are driving growth of the market are increasing chronic diseases prevalence, and surge in demand for vaccines.
Various companies have made organic growth strategies in the hypodermic needles market. Some of the activities undertaken by the company, which have promoted its growth are, launches, enhancements and expansion & relocation activities. Companies such as BD, Cardinal Helath amongst others are some of the companies that have been implementing various organic strategies that have helped the growth of the company.
The drug delivery segment is growing at the highest CAGR owing to increasing prevalence of chronic disease.
New product launches, and acquisitions have helped the growth of market players across emerging regions.
The List of Companies - Hypodermic Needles Market
- EXELINT International, Co.
- Terumo Corporation
- BD
- B. Braun Melsungen AG
- Catalent Inc
- Cardinal Health Inc
- Vita Needle Company
- Connecticut Hypodermics Inc.
- Vygon
- Nipro
- Barber of Sheffield
- RETRACTABLE TECHNOLOGIES, INC.
- AIR-TITE PRODUCTS CO., INC.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Global Hypodermic Needles Market
Nov 2021
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Nov 2021
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2021
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2021
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2021
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2021
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2021
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Nov 2021
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)